View Clinical Trial (Medical Research Study)
Database Surveillance Safety Study of PENTACEL® Vaccine - NCT00804284-94612(Clinical Trial 257900)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
Oakland |
|
State:
|
|
CA |
| Zip Code: |
|
94612 |
| Conditions: |
|
Diphtheria - Tetanus - Pertussis - Haemophilus Influenzae |
| Purpose: |
|
The objective for this study is to characterize the safety profile of PENTACEL® vaccine for
identification of potential vaccine-related adverse events not currently associated with
PENTACEL® vaccine administration.
|
| Study summary: |
|
The study will be conducted at Kaiser Permanente Northern California and will commence with
first use of licensed PENTACEL® vaccine within that organization.
Vaccination databases will be reviewed to identify DTaP vaccinations of accrued subjects.
Medical encounter, emergency room, hospitalization, laboratory, state death reporting, and
related databases will be reviewed to identify medical care events. |
| Criteria: |
|
Inclusion Criteria:
- Receipt of DTaP vaccine during the study period by a previously unvaccinated child
Exclusion Criteria:
- None |
|
|
|
| Study is available at: |
|
Oakland, CA 94612
United States
Primary Contact:
Public Registry Sanofi Pasteur
Email: RegistryContactUs@sanofipasteur.com |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
March 22, 2011 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|